Ndt Pharmaceuticals Stock Net Income
| NDTP Stock | USD 1.89 0.01 0.53% |
NDT Pharmaceuticals' fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting NDT Pink Sheet price.
NDT |
NDT Pharmaceuticals Company Net Income Analysis
NDT Pharmaceuticals' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, NDT Pharmaceuticals reported net income of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The net income for all United States stocks is 100.0% higher than that of the company.
NDT Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NDT Pharmaceuticals' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of NDT Pharmaceuticals could also be used in its relative valuation, which is a method of valuing NDT Pharmaceuticals by comparing valuation metrics of similar companies.NDT Pharmaceuticals is currently under evaluation in net income category among its peers.
NDT Fundamentals
| Current Valuation | 123.75 K | |||
| Shares Outstanding | 1.12 M | |||
| Price To Book | 49.36 X | |||
| Earnings Per Share | (1.86) X | |||
| Market Capitalization | 1.11 M |
About NDT Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NDT Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NDT Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NDT Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with NDT Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NDT Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NDT Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against NDT Pink Sheet
The ability to find closely correlated positions to NDT Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NDT Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NDT Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NDT Pharmaceuticals to buy it.
The correlation of NDT Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NDT Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NDT Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NDT Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for NDT Pink Sheet Analysis
When running NDT Pharmaceuticals' price analysis, check to measure NDT Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NDT Pharmaceuticals is operating at the current time. Most of NDT Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NDT Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NDT Pharmaceuticals' price. Additionally, you may evaluate how the addition of NDT Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.